Following the acquisition, Bergstrom Nutrition will be part of Balchem’s Human Nutrition and Health business segment and integrated into the Minerals & Nutrients business unit.
Balchem Corporation (New Hampton, NY) has announced the acquisition of leading methylsulfonylmethane (MSM) manufacturer Bergstrom Nutrition (Vancouver, WA). Bergstrom’s MSM brand OptiMSM carries a GRAS (generally recognized as safe) designation. Following the acquisition, Bergstrom Nutrition will be part of Balchem’s Human Nutrition and Health business segment and integrated into the Minerals & Nutrients business unit.
“We are excited to welcome Bergstrom Nutrition to Balchem. As the MSM market leader, Bergstrom Nutrition has excelled in advancing the science and presence of MSM globally,” said Ted Harris, chairman, CEO and president of Balchem, in a press release. “The addition of OptiMSM to our portfolio provides a synergistic scientific advantage in Balchem’s key strategic therapeutic focus areas such as longevity and performance and is a strong fit with Balchem’s specialty, science-backed mineral products. We look forward to expanding marketplace opportunities together.”
“We are very pleased to join such a high quality, scientifically driven organization as Balchem,” offered Adrian Polliack, Bergstrom Nutrition’s president and CEO. “OptiMSM aligns well with Balchem’s already robust portfolio and complements their strategic health benefit platforms. Joining Balchem allows for accelerated growth and market reach and we look forward to working together with the Balchem team.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.